The PCORI Emerging Health Care Innovation Briefs, which expand on the Biweekly COVID-19 Scans, highlight important topics of interest identified during the ongoing scanning and topic identification process or through the ECRI stakeholder survey process.
The Innovation Briefs also highlight information on potentially disruptive developments across the PCORI Health Care Horizon Scanning System's 5 other focus areas—Alzheimer’s disease and other dementias, cancer, cardiovascular diseases, mental and behavioral health conditions, rare diseases—and high-level trends cutting across multiple focus areas. The COVID-19 pandemic also caused impacts and disruptions across the entire health care system, Therefore, the scope of these Briefs include all horizon scanning focus areas, including infectious diseases and COVID-19. View all the Emerging Health Care Innovation Briefs below.
Recent Innovation Briefs
- Treating Alzheimer's Disease and Using Artificial Intelligence to Manage Chronic Conditions (November 9-22, 2023)
- Artificial Intelligence, Preventing Invasive Meningococcal Disease and Treating Narcolepsy (October 26-November 8, 2023)
- Preventing Influenza and Cytomegalovirus Infection (October 12-25, 2023)
- Treating Relapsed or Refractory Adult B-Cell Acute Lymphoblastic Leukemia and Early Alzheimer’s Disease (September 28-October 11, 2023)
- Treating Early-Stage Choroidal Melanoma and Congenital Myotonic Dystrophy Type 1 (September 14-27, 2023)
- Treating Stargardt Disease and Hypoxic-Ischemic Encephalopathy (August 31-September 13, 2023)
- Treating Post-COVID Conditions and Preventing Fetal and Neonatal Alloimmune Thrombocytopenia (August 17-30, 2023)
- Treating Social Anxiety Disorder and Postpartum Depression (August 3-16, 2023)
- Preventing COVID-19 and Lyme Disease (July 20-August 2, 2023)
- Treating Cannabis Use Disorder and Serous Ovarian Cancer (July 6-19, 2023)
- Treating Duchenne Muscular Dystrophy and Osteogenesis Imperfecta (June 22-July 5, 2023)
- Treating High-Risk Melanoma, and Newly Diagnosed Glioblastoma Multiforme (June 8-21, 2023)
- Early-Onset Metachromatic Leukodystrophy, Recurrent Clostridioides difficile Infection (May 25-June 7, 2023)
- Treating Sexually Transmitted Infections and Urinary Tract Infections (May 11-24, 2023)
- Two Potential Treatments for Early Alzheimer’s Disease (April 27-May 10, 2023)
- Treating Fatigue Associated with Post-COVID Conditions, Agitation in Alzheimer's Disease (April 13-26, 2023)
- Treating Achondroplasia, Surgery for Peritoneal Carcinomatosis (March 30-April 12, 2023)
- Metformin for Post-COVID Conditions, Treating Pediatric Graft-vs-host Disease (March 16-29, 2023)
- Treatments for Alcohol Use Disorder and a Autonomic Nervous System Disorder (March 2-15, 2023)
- Maternal Vaccine for RSV, Treating Post-COVID Cognitive Impairment (February 16-March 1, 2023)
- Treatment for Major Depressive Disorder, Reducing Risk of Multiorgan Injury (February 2-15, 2023)
- Low-Dose Lithium for Post-COVID Conditions, Treating Pediatric Low-Grade Glioma (January 19-February 1, 2023)
- Treating Alzheimer's Disease and Symptomatic COVID-19 Outpatients (January 5-18, 2023)
Horizon scanning is a systematic process that serves as an early alert system to inform decision makers about possible future opportunities and threats. Health care horizon scanning identifies technologies, innovations, and trends with the potential to cause future shifts or disruptions—positive or negative—in areas such as access to care, care delivery processes, care setting, costs of care, current treatment models or paradigms, health disparities, health care infrastructure, public health, and patient health outcomes.
The PCORI Health Care Horizon Scanning System (HCHSS) conducts horizon scanning to better inform research investments at the Patient-Centered Outcomes Research Institute (PCORI). PCORI defines the HCHSS project scope to focus on interventions with high potential for disruption in the United States in the next 12 months within 6 focus areas: Alzheimer’s disease and other dementias, cancer, cardiovascular diseases, infectious diseases (including COVID-19), mental and behavioral health conditions, and rare diseases. In addition, the system captures high-level disruptive trends across all clinical areas, which may lead PCORI to expand the project scope to include other focus areas in the future.
The HCHSS produces 3 main outputs:
- Emerging Health Care Innovation Brief provides ECRI Horizon Scanning with a vehicle to inform PCORI and the public in a timely manner of important topics of interest identified during ongoing scanning and topic identification or through the ECRI stakeholder survey process.
- PCORI’s Horizon Scanning Database offers health care decision makers findings about advancements in the HCHSS’s 6 focus areas. This database can be used by patients, care partners, and others to track advancements in care options.
- High Potential Disruption Reports (every 6 months) for individuals with vested interests in new technologies, services, and innovations. It might provide critical insights and information about the areas in which they have a vested interest, which might include their vision and plans for how they intend to adopt an innovation. These reports highlight those topics that stakeholders (eg, patients, physicians, nurses, allied health professionals, public health professionals, first responders, health systems experts, clinical engineers, researchers, business and finance professionals, and information technology professionals) identified as having potential for high disruption.
In January 2023, the HCHSS Biweekly COVID-19 Scans were broadened in scope to include any emerging intervention in the HCHSS and renamed as the Emerging Health Care Innovation Brief.
For more information about the PCORI Health Care Horizon Scanning System, please see https://horizonscandb.pcori.org/about.
We welcome your comments on the Briefs at [email protected].
|The PCORI Health Care Horizon Scanning System is operated by ECRI under contract to PCORI, Washington, DC (Contract No. MSA-HORIZSCAN-ECRI-ENG-2018.7.12). The content included in this document is solely the responsibility and product of ECRI and does not necessarily represent the views of the PCORI. PCORI does not make any guarantees with respect to the accuracy or reliability of the information in this content, nor does PCORI necessarily endorse the content or results contained therein.|
This work is made available under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0 International).
For more information: https://creativecommons. org/licenses/by-nc-nd/4.0/.
What's Happening at PCORI?
The Patient-Centered Outcomes Research Institute sends weekly emails about opportunities to apply for funding, newly funded research studies and engagement projects, results of our funded research, webinars, and other new information posted on our site.